Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: Reversal of Ketamine Pharmacodynamic Effects With Naloxone [Phase 4]

View source ↗

Summary

A Phase 4 trial investigated whether naloxone can reverse the pharmacodynamic effects of ketamine in pain conditions. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Naloxone (Naloxone)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Pain | Phase 4 | Status: TERMINATED